The chemoradiation paradigm in head and neck cancer-Reference-Cited by-同舟云学术

The chemoradiation paradigm in head and neck cancer

Published:2007-03 Issue:3 Volume:4 Page:156-171
ISSN:1743-4254
Container-title:Nature Clinical Practice Oncology
language:en
Short-container-title:Nat Rev Clin Oncol

Author:

Seiwert Tanguy Y,Salama Joseph K,Vokes Everett E

Publisher

Springer Science and Business Media LLC

Subject

Oncology,General Medicine

Link

http://www.nature.com/articles/ncponc0750.pdf

Reference103 articles.

1. Parkin DM et al. (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153–156

2. Jemal A et al. (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43–66

3. NCI-SEER Survival (1995–2001) Oral Cavity and Pharynx, Larynx. Surveillance Epidemiology and End Results (SEER) database [ http://seer.cancer.gov/ ] (accessed 19 March 2006)

4. Saunders MI and Rojas AM (2004) Management of cancer of the head and neck–a cocktail with your PORT? N Engl J Med 350: 1997–1999

5. Seiwert TY and Cohen EE (2005) State-of-the-art management of locally advanced head and neck cancer. Br J Cancer 92: 1341–1348

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation of Chemotherapy and Radiation Therapy with Atypical Oral Cellular Changes: A Cytological Study in Cancer Patients;Biomedical Research and Therapy;2024-05-31

2. Efficacy and Safety of Paclitaxel versus Cisplatin with Concurrent Radiotherapy in Central India Patients with Locally Advanced Head-and-neck Cancers: A Randomized, Open-label Study;Journal of Radiation and Cancer Research;2024-05-27

3. Phosphate Coordination to Metal‐Organic Layer Secondary Building Units Prolongs Drug Retention for Synergistic Chemoradiotherapy;Angewandte Chemie;2024-03-11

4. Phosphate Coordination to Metal‐Organic Layer Secondary Building Units Prolongs Drug Retention for Synergistic Chemoradiotherapy;Angewandte Chemie International Edition;2024-03-08

5. Adverse Event Profile and Compliance of Docetaxel with Radiation in Cisplatin-Ineligible Patients of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Research Protocol;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2024